Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Drought is over, turn around day
View:
Post by canadafan on Apr 20, 2021 12:58pm

Drought is over, turn around day

After a pre- announcement run up, The price as we know dropped off daily.
I know a few people who are T.A traders predcting we are close to or even past the recent bottom.
further evidence, most broad markets are down today. Onc is boarder line  up & down.
Showing some good late am recovery.
fundamentals?
never been better. I expect to hear about a car- T partnership. My guess before end of this year.
the aware-1, did meet endpoints. However Pfizer has a first right of refusal,& that comes into play pending bracelet study.
THAT is what killed the price. Not bad news, but again, more time needed.
the Car-t deal will come out of the blue. Surprise everyone. It also will be a long timeline, but if promoted correctly, will boost price & credibility.
without pending, " news" the price is victim to trading, shorting etc.
long term?
look at the 9 month chart
the lows keep getting higher.
Comment by fox7mf on Apr 20, 2021 2:33pm
A partnership deal could come at any point in 2021, and the same could be said for an out & out buyout.
Comment by Normandt1965 on Apr 20, 2021 3:42pm
Excellent post canadafan, as always !!
Comment by HCallahann44 on Apr 20, 2021 4:03pm
Agree things look positive but why did Pfizer right of first refusal sink the price? not following that one. Just worry about the FDAs upcoming decision on the CI drugs....I wonder if that is weighing on our stock
Comment by canadafan on Apr 20, 2021 5:00pm
Pfizer & Onc have a co- development " deal " signed about 2 yrs ago. pending the Bracelet results, Pfizer will have first look, alongside Onc mangement. they will have 60 days to produce a financial offer, to move forward with phase 3. durring, that 60 days. No data will be made public. assuming Pfizer & Onc do not reach a deal, the data becomes public & Onc can shop the ...more  
Comment by fox7mf on Apr 20, 2021 5:22pm
Great...and to echo Normandt1965, thank you for your insightful and studied contributions Canadafan.
Comment by HCallahann44 on Apr 20, 2021 8:07pm
Thx Canada...still don't get why that knocks 50% off the price. ONCY seems to be in the sweet spot of the new Immunotherapy trend...why partner with anyone?...its almost as if we are an early Microsoft---providing the "software" that will make all the immunotherapy drugs go....makes no sense to me that the stock price keeps tanking....
Comment by stayhumble1 on Apr 20, 2021 8:40pm
Canadafan, you say "the Bracelet results are 6-12 months away (some prelim results as early as 6 months). What is your source or reference for that time frame? The information provided on the NIH Clinical Trials website in the Study Design section (last updated Mar30/2021) states the Bracelet Primary Completion Date is May 2021 and the Estimated Study Completion Date is June 2021...  ...more  
Comment by Journeytc on Apr 20, 2021 9:45pm
ONC'S latest presentation slide 9 says Q4. So yes there seems to be a delay in the trial by six months
Comment by Journeytc on Apr 20, 2021 9:46pm
add the Pfizer confidentiality to get the year
Comment by HCallahann44 on Apr 21, 2021 9:13am
thx for posting. now I get it...still disagree that this should cause a 50 percent haircut
Comment by Normandt1965 on Apr 21, 2021 9:46am
Come on, stop focusing on the peaks.....check the general progression on 1 year, one year and a half. Look at the chart on 1 year.....steady ramp up. I bought at 0.74 in 2019. Now it's almost 4$ can. Then it's a strong positive progression, not a 50% haircut at all.
Comment by westcoast1000 on Apr 21, 2021 12:24pm
Norman, You were a wise person to buy at .74 (US?) in 2019. Many of us had large holdings for five years or more at that point. For new ONCY holders, IN my opinion, Canadafan provides honest straight assessments of where the company sits. It is completely true that things have never looked stronger. And yes, there can still be a big sell-off. People generally feel they can flip this stock ...more  
Comment by Normandt1965 on Apr 21, 2021 12:55pm
Hi West, No I bought at 0.74 Can funds.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities